每(mei)經AI快訊，傲(ao)(ao)農(nong)(nong)(nong)生物(wu)（SH 603363，收盤價(jia)(jia)：5.6元(yuan)(yuan)）1月10日晚間發布公(gong)(gong)(gong)告(gao)稱(cheng)，國貿(mao)傲(ao)(ao)農(nong)(nong)(nong)系(xi)由福(fu)建傲(ao)(ao)農(nong)(nong)(nong)生物(wu)科技集團股(gu)份(fen)有(you)(you)限公(gong)(gong)(gong)司與廈門(men)國貿(mao)農(nong)(nong)(nong)產(chan)品(pin)(pin)有(you)(you)限公(gong)(gong)(gong)司共同(tong)投資(zi)設立，公(gong)(gong)(gong)司持有(you)(you)國貿(mao)傲(ao)(ao)農(nong)(nong)(nong)49%股(gu)權(quan)(quan)，國貿(mao)農(nong)(nong)(nong)產(chan)品(pin)(pin)持有(you)(you)國貿(mao)傲(ao)(ao)農(nong)(nong)(nong)51%股(gu)權(quan)(quan)。鑒(jian)于(yu)公(gong)(gong)(gong)司戰略發展規劃，為(wei)進一(yi)(yi)步(bu)優化資(zi)源配置，聚焦(jiao)于(yu)核心主業，逐步(bu)剝離附屬業務(wu)，同(tong)時通過出(chu)售資(zi)產(chan)方式回收資(zi)金改善公(gong)(gong)(gong)司現(xian)金流(liu)，公(gong)(gong)(gong)司擬將持有(you)(you)的(de)國貿(mao)傲(ao)(ao)農(nong)(nong)(nong)49%股(gu)權(quan)(quan)（對(dui)應(ying)認繳注冊資(zi)本(ben)9800萬(wan)元(yuan)(yuan)、實繳出(chu)資(zi)4900萬(wan)元(yuan)(yuan)）按5219.79萬(wan)元(yuan)(yuan)的(de)價(jia)(jia)格轉讓給國貿(mao)農(nong)(nong)(nong)產(chan)品(pin)(pin)。根據廈門(men)嘉學資(zi)產(chan)評(ping)估(gu)房地產(chan)估(gu)價(jia)(jia)有(you)(you)限公(gong)(gong)(gong)司出(chu)具的(de)嘉學評(ping)估(gu)評(ping)報(bao)字〔2023〕8100045號《資(zi)產(chan)評(ping)估(gu)報(bao)告(gao)》，國貿(mao)傲(ao)(ao)農(nong)(nong)(nong)在評(ping)估(gu)基準日的(de)股(gu)東全部權(quan)(quan)益賬(zhang)面(mian)價(jia)(jia)值為(wei)約1.06億元(yuan)(yuan)，評(ping)估(gu)價(jia)(jia)值為(wei)約1.07億元(yuan)(yuan)，增值額為(wei)24.7萬(wan)元(yuan)(yuan)，增值率為(wei)0.23%。在評(ping)估(gu)基礎(chu)上經交易(yi)雙方協商一(yi)(yi)致同(tong)意，國貿(mao)傲(ao)(ao)農(nong)(nong)(nong)49%股(gu)權(quan)(quan)轉讓交易(yi)價(jia)(jia)格確定為(wei)5219.79萬(wan)元(yuan)(yuan)。

2023年(nian)1至6月份，傲(ao)農(nong)生物(wu)的營業(ye)(ye)收入構成為：飼料(liao)及動保行業(ye)(ye)占比(bi)(bi)53.45%，飼養行業(ye)(ye)占比(bi)(bi)28.42%，食品占比(bi)(bi)14.8%，貿易占比(bi)(bi)3.0%，其他占比(bi)(bi)0.01%。

傲(ao)農生物的(de)總(zong)經理、董事長均(jun)是吳有林，男，46歲，學(xue)歷(li)背景為(wei)大專。

截至發稿，傲農生物市(shi)值為(wei)49億元(yuan)。

道達號（daoda1997）“個股趨勢”提醒：
1. 傲農生物近30日內北向資金持股量增加39.82萬股，占流通股比例增加0.06%；
2. 近30日內無機構對傲農生物進行調研。

每經頭條（nbdtoutiao）——

(記者 曾健輝)

免責聲明(ming)：本文(wen)內(nei)容與數據僅(jin)供(gong)參考，不(bu)構成投資建議(yi)，使用前請核實(shi)。據此操(cao)作，風險自擔。